A clinical trial assessing EGL-003
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs EGL-003 (Primary)
- Indications Autoimmune disorders; Cancer
- Focus Adverse reactions
- 17 Jan 2025 New trial record
Latest Information Update: 17 Jan 2025